Saturday, June 20, 2020 9:25:45 PM
Yes,, and I am not trying to say anyone is wrong. All of us Longs are right. I have a different Big Picture than anyone. It changes . Never static . It's dynamic. As the situation changes I change. My Big Picture, others in todays world call it my Vision. I like Big Picture and I have used it since the 1970s.
One company where I made a huge return? I'm thinking you might not think I'm real.
In the fall of 1990 I invested as the lead investor / negotiator and soon to be syndicate manager in a small venture Cap deal. I put three Paulson brokers into it. Yes, the same Paulson that has raised millions for CYDY. All of my Paulson Pals have retired BUT with due diligence you can find one of the two survivors. We had 1 cent Warrants on MTON the directory assistant service for all Cell companies for around 15 to 20 years. 1 Cent Warrants.
Now, if you investigate with the all Top Execs of Paulson and mention MTON, someone will verify this. Two young pups that I knew in the 1980s are now the Top Dogs at Paulson. That hit was legendary.
That 1 cent hit a high of >>>> drum roll, bugles, drums and bugle... 69$
So that seems to be 6900 X my 1 cent. I guess that might be a decent return.
Back to CYDY. One product? Yes but better than all drug companies stable of products combined. We will rule.
One company where I made a huge return? I'm thinking you might not think I'm real.
In the fall of 1990 I invested as the lead investor / negotiator and soon to be syndicate manager in a small venture Cap deal. I put three Paulson brokers into it. Yes, the same Paulson that has raised millions for CYDY. All of my Paulson Pals have retired BUT with due diligence you can find one of the two survivors. We had 1 cent Warrants on MTON the directory assistant service for all Cell companies for around 15 to 20 years. 1 Cent Warrants.
Now, if you investigate with the all Top Execs of Paulson and mention MTON, someone will verify this. Two young pups that I knew in the 1980s are now the Top Dogs at Paulson. That hit was legendary.
That 1 cent hit a high of >>>> drum roll, bugles, drums and bugle... 69$
So that seems to be 6900 X my 1 cent. I guess that might be a decent return.
Back to CYDY. One product? Yes but better than all drug companies stable of products combined. We will rule.
Recent CYDY News
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
